🇺🇸 FDA
Pipeline program

KT-474/Placebo

KT474-HV-101

Phase 1 small_molecule completed

Quick answer

KT-474/Placebo for Healthy Volunteer is a Phase 1 program (small_molecule) at Kymera Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Kymera Therapeutics
Indication
Healthy Volunteer
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials